In This Issue 
October 2021
We hope this note finds you safe and well as the world begins to breath a bit easier as the challenges of a pandemic subside. As our businesses are all on the front lines of healthcare and life sciences we continue to be honored (and amazed) by the spirit and dedication to succeed during these trying times.

We are pleased to report that through September 2021, Paragon Ventures closed a record number and breadth of transactions through the pandemic. Collectively, our clients represented over $165MM in revenues and a broad base of care initiatives.

Inside this edition, we have a healthy selection of new acquisitions opportunities across several healthcare sectors. From healthy living products to biologic therapies we have something of beauty across the continuum of care.

If the time is right for you and your business, the healthcare M&A markets are strong and some sectors offering unprecedented valuations and options for management through a strategic transaction. As always we welcome your inquires and continue to hold all discussions strictly confidential. Text Link
You Are Invited To Join Us
business_conference4.jpg
The Paragon Ventures Transactions Team Is FINALLY Back On The Road To Meet You!
Join Paragon Ventures at Medtrade East
 
Medtrade events are the largest trade shows in the U.S. focused exclusively on the home medical equipment market. Medtrade East is designed to give today’s providers the highest quality education, networking opportunities, and a large selection of HME products all under one roof. We invite you to join us in Atlanta—register through the link below to receive a free expo pass*.
 
Visit us in booth # 1053
 
Paragon Ventures is a leading investment banking advisory for healthcare business mergers and acquisition services. Established in 1994, we have successfully represented over 300 healthcare companies in M&A transactions. Our experience has taught us to use a strategic focus, anticipate hurdles and guide our clients to successfully navigate to a closing. The current M&A markets are strong with motivated buyers and investors. Explore your STRATEGIC options to sell or merge your business. 
 
Register to attend Medtrade East below using the FREE Expo Pass Code: EXIV152419


 
If you can’t make it to Atlanta next week, please call us at 800-719-1555
or click here to schedule a complimentary consultation with one of our professional advisors. All inquiries held strictly confidential.

Join Paragon Ventures at
Asembia Specialty Pharmacy Summit 2021
 
ASEMBIA'S SPECIALTY PHARMACY SUMMIT WILL TAKE PLACE OCTOBER 26-29, 2021 AT THE WYNN LAS VEGAS.

The Specialty Pharmacy Summit is an in-person event comprised of networking, sessions, exhibits and more. Asembia's Specialty Pharmacy Summit is at the epicenter of the specialty pharmacy industry, providing a unique opportunity for stakeholders throughout to understand challenges, generate solutions and define the future.
 
Visit us in booth # 309
 
Paragon Ventures is a leading investment banking advisory for healthcare business mergers and acquisition services. Established in 1994, we have successfully represented over 300 healthcare companies in M&A transactions. Our experience has taught us to use a strategic focus, anticipate hurdles and guide our clients to successfully navigate to a closing. The current M&A markets are strong with motivated buyers and investors. Explore your STRATEGIC options to sell or merge your business. 
 
Register below for a confidential meeting with Paragon Ventures
 

  
If you can’t make it to Las Vegas for the Asembia Summmit please call us at 800-719-1555 or click here to schedule a complimentary consultation with one of our professional advisors. All inquiries held strictly confidential.

When The Time Is Right...
Paragon Ventures
AVAILABLE FOR ACQUISITION
Infusion Pharmacy Services
Listing Number - PN321-14020
Revenue Size - 14.3MM

Click below for a Profile At A Glance on this opportunity

For more information contact Paragon Ventures
415-786-8153 |mobile|



AVAILABLE FOR ACQUISITION
Long Term Care Nurse Staffing
Listing Number - SE320-20015
Revenue Size - 15 MM

Click below for a Profile At A Glance on this opportunity

For more information contact Paragon Ventures
Call: 800-719-1555 Ext. 203 or 215-356-8003 (cell)


AVAILABLE FOR ACQUISITION
Skin Care: Aesthetic Device Manufacturer / Distributor
Listing Number - US321-08016
Revenue Size - 8 MM

Click below for a Profile At A Glance on this opportunity

For more information contact Paragon Ventures
800-719-1555 Ext. 205 or 603-661-7188 (cell)


AVAILABLE FOR ACQUISITION
International Patented Medical Device
Manufacturer, Distributor
Listing Number - EU319-14600
Revenue Size - 1.3 MM

For more information, 
Contact Tony Marsallo
Call: 800-719-1555, Ext 209 or (315) 559-3140 (mobile) 
AVAILABLE FOR ACQUISITION
Medical Cardiology Supply Specialists
Kitting Manufacturer
Listing Number - NE319-04025
Revenue Size - 4.8 MM
Cardiology focused Medical Supply Business with an extensive inventory of cardiology equipment and supplies selling to hospitals, medical offices and medical supply companies. In addition to supplying the most respected, major brands in cardiology, the Company is a manufacturer of custom kits for cardiology event recording and testing. The Company is a leading supplier for cardiology providers including echo/ultrasound, cardiac testing and monitoring equipment and supplies. The Company serves thousands of of medical professionals and their patients in the United States and globally.

For the trailing twelve months ending January 2021 the business generated $4.8MM and generated $775,000 EBITDA. The business is well positioned for continued growth and expansion. Additional information is available to qualified buyers.


For more information, 
Contact Tony Marsallo
Call: 800-719-1555, Ext 209 or (315) 559-3140 (mobile) 

DEAL ANNOUNCEMENTS
Recent Transaction Closings

Paragon Ventures is pleased to announce the sale of its client,
Marra's Homecare


THE BUYER 
KPH Healthcare Services is a national provider of pharmaceutical and health care services with complementary businesses in both the retail and commercial segments of the industry.

THE SELLER 
Marra’s Homecare is a family owned HME company specializing in Respiratory and Rehab equipment and services. For over 30 years Marra's has grown multiple locations throughout Upstate New York. 

If you would like more information about this transaction or Paragon Ventures contact Tony Marsallo, Managing Director of Paragon Ventures at 315-559-3140 or via email at tmarsallo@paragonventures.com
Paragon Ventures is pleased to announce the sale of its client, OlyHealth


THE BUYER 
Adapt Health is an national leader providing respiratory and medical supplies to patients throughout the United States.

THE SELLER 
OlyHealth / Olympia Respiratory Services is a provider of respiratory, sleep and CPAP supplies with 6 locations throughout Washington State.


If you would like more information about this transaction or Paragon Ventures contact April Mason, Managing Director of Paragon Ventures at 603-661-7188 or via email at amason@paragonventures.com
Paragon Ventures is pleased to announce the sale of its client,
Infiniti Medical Solutions


THE BUYER 
The buyer is a regional providers of high tech respiratory equipment to long term care facilities.

THE SELLER 
Infiniti is a regional provider of high tech respiratory equipment including ventilators and respiratory assist devices.




If you would like more information about this transaction or Paragon Ventures contact Jonathan Sadock, Paragon Ventures CEO at 610-331-6900or via email at jsadock@paragonventures.com
Paragon Ventures is pleased to announce the sale of its client, Aircare Medical to Lincare.


THE BUYER 
Lincare is an national leader providing respiratory and medical supplies to patients throughout the United States.

THE SELLER 
Aircare Medical SMRT Sleep is a provider of respiratory equipment and sleep therapy equipment and CPAP supplies located in California.




If you would like more information about this transaction or Paragon Ventures contact Scott Fife, Vice President at 215-356-8003 or via email at sfife@paragonventures.com
Dollars & Sense on Valuations
Valuation has always been a pivotal factor in a business owner’s decision to sell. There are frequently additional motivating factors such as retirement, health, business opportunities, stress, and a variety of others, but they are usually coupled with an ability to obtain the right price and terms for the business.  

At no cost or obligation, we provide an analysis on the business that covers value and other market realities so you understand how much your business is worth in the current market.  We do this to help a business owner to make informed decisions before making any commitments to market and sell their business. Click here to read more of this article...
The Paragon Ventures Market Pulse website provides insight into healthcare mergers and acquisitions processes and notable completed transactions across many sectors. Out team is in market discussions with active buyers and investors across the continuum of care. We use this information to provide strategic insights into successful transactions across the healthcare and life sciences sectors.


This information has been compiled from publicly available press releases and Paragon Ventures market research activities. This information has been compiled with publicly available information. Contact us for more information and insights into the strategic options available for your business in the current market.

Below are requests we have received from prequalified prospective buyers and investors. They reflect a small portion of the requests we receive on a daily basis.

If you are considering a potential sale or investment in your healthcare company, we welcome the opportunity to contact us to Explore and Execute Your Strategic Options.


Buyer & Investor Inquiries

  • We are interested in acquiring a Hospice business and operate it under our umbrella Our primary target markets are South and North Carolina, Tennessee, Georgia, Florida, Virginia.
  • I'm interested in companies operating in the healthcare RCM space.
  • Looking for home health in Dallas area and in Phoenix area.
  • Focused predominately on medical devices/technology, outsourced services, multi-site facilities and other near adjacent markets.
  • $20MM revenue software, saas, and tech businesses
  • Healthcare businesses with at least $3 Million in EBITDA. Perfer businesses with no customer that's comprises more than 10% of revenues
  • Manufacturing and essential services in Florida
  • Looking for respiratory businesses
  • 503A and 503B pharmacies
  • home care in palm beach or florida in general
  • I need a hme /dme in Nc with uhc, and aetna and humana contracts
  • Behavioral Health companies over $3MM revenues (anywhere)
  • Looking for a business with highly recurring or repeatable revenue in an industry that is growing. Open to any geographic location. Happy to discuss further criteria.
  • We are a family office interested in purchasing hospice businesses in the midwest. We are headquartered in Chicago.
  • Orthotics and Prosthetics
  • We look for businesses with $1-$5M of EBITDA and highly recurring revenue. We generally prefer services businesses with a focus on equipment maintenance and repair.
  • We are a long-term lower middle market investment group based in St. Louis, MO. Transactions typically are in the $5M - $50M of EV range but can go higher or lower for the right opportunity. We are focused on equipment going into medical device, pharmaceutical or laboratory settings. Additionally, anything that touches the testing and validation process, service or equipment, are of interest.
  • New England; EBITDA 750K+ or Revenue 3M+ - Ancillary Support Services, Behavioral Health Services, Healthcare Financial Services, Healthcare Provider, Home Health / Hospice, Medical Device, Medical Supply
  • Retail pharmacies
  • B2B Services such as healthcare or industrial technology/equipment-related services; regulatory compliance software and services; other business service
  • EBITDA of $1M to ~$4M annually
  • Pharmacies - retail, specialty, 340B
  • Skilled Home Health and Hospice; up to $10MM purchase price.
  • looking to a acquire a revenue cycle management, medical billing, or medical claims company with revenues greater than $1.0m. We are generally agnostic to geography.
  • Acquisition opportunities in the pharmacy sector
  • Clinical Laboratories in the state of California. Platform of 20-60million in sales. Small labs with ebitda from 800k, 1m-5m.
  • medical equipment/respiratory/mobility industry, and another focused more on behavioral health services
  • We are seeking a company generating between 2 and 10 M EBITDA with scale-up potential, room for operational efficiencies and institutionalization. Preferably with operations in the Sun Belt Region of the United States
  • Clinical practices (dental, O&P, IVF, etc.), healthcare technology and medical devices. 750K SDE minimum, 3M-7M target
  • interested in the healthcare, technology, business services industries and in rental business models
  • We are looking to acquire and operate a business with $1-5M EBITDA
  • We're looking for multiple acquisitions in the healthcare industry for a roll up into our public company. We're hoping to eclipse $3bb in revenue worldwide within the next 4 years.
  • Businesses in the biotech area.
  • Home Health Agency, open to size.
  • Nursing and Allied medical Staffing
  • Medical practices in all of Florida $2m-$10m
  • Ancillary Support Services, Behavioral Health Services, Healthcare Financial Services, Healthcare Provider, Home Health / Hospice, Medical Supply, Other, Pharmacy
  • We are looking to purchase 10 + urgent cares, ideally in Texas to start with plans to expand nationally. We are looking for an EBITDA of 2M to 5M.
  • Adult Mental Health, Child Pediatric Health
  • We are a large Home Care agency located in NY. We are looking to expand to Florida, and Pennsylvania.
  • DME companies who provide continuous glucose monitoring (CGM) systems.
The Strength of Healthcare M&A
Now and On The Horizon
Watch for the next issue of Paragon InSight:

Strategic Private Equity's Love Affair with Healthcare M&A
When considering the sale, merger or recapitalization of your healthcare business there are many strategic options worthy of consideration. Your personal and business goals in a transaction will ultimately lead you in a specific direction to consummate what is often a “once in a lifetime” transaction.  As you chart the course, it is vital to understand not only your own business (See our article “If You Don’t Know Your Numbers, You Don’t Know Your Business”) but also the various buyers and investors that may be interested in acquiring or partnering with you in a transaction. 

This article is written to give a high-level overview of private equity groups (PEGs) and their interests within healthcare and life science businesses. The Covid19 pandemic has been one of the largest challenges mankind has ever experienced. The impact and focus on healthcare throughout the crisis has pushed many healthcare businesses to their absolute limit. While others have stepped up to the challenges and their adaptive business models are feeding a voracious appetite from both private equity and corporate buyers alike....

Watch for the rest of this article in the next edition of Paragon Ventures Market Pulse Insight.
We are wrapping up some new opportunities which will soon be available in market



The Paragon Ventures Private Client Group M&A Team
800-719-1555